BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10458986)

  • 1. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis.
    Speck SH; Virgin HW
    Curr Opin Microbiol; 1999 Aug; 2(4):403-9. PubMed ID: 10458986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection.
    Virgin HW; Speck SH
    Curr Opin Immunol; 1999 Aug; 11(4):371-9. PubMed ID: 10448140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.
    Kayhan B; Yager EJ; Lanzer K; Cookenham T; Jia Q; Wu TT; Woodland DL; Sun R; Blackman MA
    J Immunol; 2007 Dec; 179(12):8392-402. PubMed ID: 18056385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
    Rajćáni J; Kúdelová M
    Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma interferon blocks gammaherpesvirus reactivation from latency.
    Steed AL; Barton ES; Tibbetts SA; Popkin DL; Lutzke ML; Rochford R; Virgin HW
    J Virol; 2006 Jan; 80(1):192-200. PubMed ID: 16352543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early establishment of gamma-herpesvirus latency: implications for immune control.
    Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
    J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
    Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
    Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency.
    van Dyk LF; Virgin HW; Speck SH
    J Virol; 2000 Aug; 74(16):7451-61. PubMed ID: 10906198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of a novel vaccination strategy for human gamma-herpesviruses.
    Wu TT; Blackman MA; Sun R
    Immunol Res; 2010 Dec; 48(1-3):122-46. PubMed ID: 20717741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-Herpesvirus-induced protection against bacterial infection is transient.
    Yager EJ; Szaba FM; Kummer LW; Lanzer KG; Burkum CE; Smiley ST; Blackman MA
    Viral Immunol; 2009 Feb; 22(1):67-72. PubMed ID: 19210230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse.
    Barton E; Mandal P; Speck SH
    Annu Rev Immunol; 2011; 29():351-97. PubMed ID: 21219186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of γHV68 infection in mice.
    Pirooz SD; Lee JH; Zhao Z; Ni D; Oh S; Liang C
    J Vis Exp; 2011 Nov; (57):. PubMed ID: 22127138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency.
    Clambey ET; Virgin HW; Speck SH
    J Virol; 2002 Jul; 76(13):6532-44. PubMed ID: 12050366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus latency and symbiotic protection from bacterial infection.
    Barton ES; White DW; Virgin HW
    Viral Immunol; 2009 Feb; 22(1):3-4; author reply 5-6. PubMed ID: 19210221
    [No Abstract]   [Full Text] [Related]  

  • 15. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.
    Weck KE; Dal Canto AJ; Gould JD; O'Guin AK; Roth KA; Saffitz JE; Speck SH; Virgin HW
    Nat Med; 1997 Dec; 3(12):1346-53. PubMed ID: 9396604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the in vivo role of a viral bcl-2.
    Gangappa S; van Dyk LF; Jewett TJ; Speck SH; Virgin HW
    J Exp Med; 2002 Apr; 195(7):931-40. PubMed ID: 11927636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of B-cell proliferation in the establishment of gammaherpesvirus latency.
    Moser JM; Upton JW; Allen RD; Wilson CB; Speck SH
    J Virol; 2005 Aug; 79(15):9480-91. PubMed ID: 16014911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune escape of γ-herpesviruses from adaptive immunity.
    Hu Z; Usherwood EJ
    Rev Med Virol; 2014 Nov; 24(6):365-78. PubMed ID: 24733560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral latency and its regulation: lessons from the gamma-herpesviruses.
    Speck SH; Ganem D
    Cell Host Microbe; 2010 Jul; 8(1):100-15. PubMed ID: 20638646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.